Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Joint Instability | 14 | 2018 | 82 | 4.590 |
Why?
|
Osteoarthritis | 17 | 2021 | 74 | 4.510 |
Why?
|
Carpometacarpal Joints | 10 | 2021 | 13 | 4.320 |
Why?
|
Tennis Elbow | 9 | 2023 | 12 | 4.150 |
Why?
|
Thumb | 8 | 2021 | 22 | 3.460 |
Why?
|
Radial Neuropathy | 4 | 2024 | 4 | 3.330 |
Why?
|
Hand | 11 | 2024 | 133 | 3.110 |
Why?
|
Joint Dislocations | 8 | 2023 | 27 | 2.880 |
Why?
|
Orthopedics | 9 | 2024 | 127 | 2.700 |
Why?
|
Fractures, Bone | 8 | 2023 | 128 | 2.600 |
Why?
|
Relaxin | 5 | 2016 | 8 | 1.960 |
Why?
|
Elbow Joint | 5 | 2023 | 30 | 1.880 |
Why?
|
Radius Fractures | 6 | 2015 | 33 | 1.850 |
Why?
|
Wrist Injuries | 5 | 2017 | 14 | 1.840 |
Why?
|
Wounds, Gunshot | 3 | 2024 | 94 | 1.780 |
Why?
|
Adrenal Cortex Hormones | 7 | 2023 | 266 | 1.630 |
Why?
|
Arthroplasty | 5 | 2021 | 28 | 1.630 |
Why?
|
Arthroscopy | 5 | 2015 | 93 | 1.610 |
Why?
|
Nerve Compression Syndromes | 2 | 2023 | 18 | 1.610 |
Why?
|
De Quervain Disease | 3 | 2021 | 7 | 1.540 |
Why?
|
Trapezium Bone | 5 | 2021 | 7 | 1.480 |
Why?
|
Humans | 111 | 2024 | 89357 | 1.480 |
Why?
|
Olecranon Process | 2 | 2021 | 3 | 1.470 |
Why?
|
Orthopedic Procedures | 7 | 2024 | 129 | 1.400 |
Why?
|
Wrist Joint | 8 | 2022 | 24 | 1.390 |
Why?
|
Tendon Transfer | 2 | 2021 | 6 | 1.330 |
Why?
|
Military Personnel | 4 | 2010 | 92 | 1.230 |
Why?
|
Musculoskeletal Diseases | 5 | 2015 | 34 | 1.160 |
Why?
|
Arm Injuries | 4 | 2017 | 10 | 1.150 |
Why?
|
Elbow | 3 | 2023 | 12 | 1.120 |
Why?
|
Cartilage, Articular | 4 | 2016 | 69 | 1.090 |
Why?
|
Workload | 3 | 2020 | 129 | 1.040 |
Why?
|
Tenosynovitis | 2 | 2021 | 7 | 1.040 |
Why?
|
Scaphoid Bone | 3 | 2010 | 6 | 1.020 |
Why?
|
Stress Disorders, Post-Traumatic | 2 | 2024 | 115 | 1.020 |
Why?
|
Humeral Fractures | 2 | 2024 | 17 | 1.010 |
Why?
|
Trigger Finger Disorder | 2 | 2023 | 5 | 1.010 |
Why?
|
Arthroplasty, Replacement, Finger | 2 | 2018 | 2 | 1.010 |
Why?
|
Male | 49 | 2024 | 42411 | 1.000 |
Why?
|
Carpal Tunnel Syndrome | 3 | 2020 | 17 | 0.980 |
Why?
|
Bursitis | 2 | 2021 | 10 | 0.970 |
Why?
|
Female | 47 | 2024 | 46202 | 0.950 |
Why?
|
Contracture | 3 | 2022 | 18 | 0.940 |
Why?
|
Fingers | 2 | 2020 | 69 | 0.930 |
Why?
|
Fracture Fixation, Internal | 4 | 2020 | 67 | 0.930 |
Why?
|
Adult | 34 | 2024 | 26607 | 0.910 |
Why?
|
Arthrodesis | 3 | 2021 | 26 | 0.900 |
Why?
|
Physical Therapy Modalities | 5 | 2022 | 83 | 0.890 |
Why?
|
Range of Motion, Articular | 5 | 2023 | 154 | 0.880 |
Why?
|
Osteogenesis | 7 | 2019 | 255 | 0.870 |
Why?
|
Wounds, Nonpenetrating | 1 | 2024 | 113 | 0.860 |
Why?
|
Middle Aged | 30 | 2024 | 25974 | 0.840 |
Why?
|
Hand Joints | 2 | 2015 | 3 | 0.830 |
Why?
|
Ganglion Cysts | 1 | 2022 | 4 | 0.820 |
Why?
|
Internship and Residency | 4 | 2014 | 1045 | 0.820 |
Why?
|
Wrist | 1 | 2022 | 22 | 0.810 |
Why?
|
Young Adult | 17 | 2024 | 6312 | 0.790 |
Why?
|
Sex Factors | 11 | 2016 | 1066 | 0.770 |
Why?
|
Emergency Medicine | 2 | 2014 | 125 | 0.760 |
Why?
|
Median Neuropathy | 1 | 2020 | 1 | 0.740 |
Why?
|
Tendon Injuries | 3 | 2016 | 36 | 0.730 |
Why?
|
Aged | 22 | 2024 | 19165 | 0.720 |
Why?
|
Open Fracture Reduction | 1 | 2020 | 4 | 0.710 |
Why?
|
Ulna Fractures | 1 | 2020 | 6 | 0.710 |
Why?
|
Military Medicine | 2 | 2010 | 20 | 0.710 |
Why?
|
Societies, Medical | 1 | 2024 | 575 | 0.710 |
Why?
|
Glucocorticoids | 4 | 2023 | 358 | 0.710 |
Why?
|
Growth Differentiation Factor 2 | 6 | 2019 | 151 | 0.680 |
Why?
|
Occupational Diseases | 1 | 2020 | 55 | 0.670 |
Why?
|
Finger Joint | 2 | 2018 | 14 | 0.670 |
Why?
|
Finger Injuries | 2 | 2018 | 12 | 0.670 |
Why?
|
Trapezoid Bone | 2 | 2009 | 2 | 0.670 |
Why?
|
Athletic Injuries | 4 | 2016 | 97 | 0.650 |
Why?
|
Risk Factors | 13 | 2024 | 5499 | 0.650 |
Why?
|
Prospective Studies | 12 | 2023 | 4289 | 0.650 |
Why?
|
Radiography | 10 | 2014 | 809 | 0.650 |
Why?
|
Radius | 2 | 2017 | 31 | 0.640 |
Why?
|
Educational Measurement | 2 | 2011 | 231 | 0.620 |
Why?
|
Evidence-Based Medicine | 2 | 2012 | 433 | 0.620 |
Why?
|
Ischemia | 1 | 2020 | 251 | 0.610 |
Why?
|
Sick Leave | 1 | 2018 | 13 | 0.610 |
Why?
|
Bone and Bones | 2 | 2019 | 269 | 0.600 |
Why?
|
Bone Density | 2 | 2018 | 209 | 0.600 |
Why?
|
Receptors, Peptide | 2 | 2014 | 22 | 0.580 |
Why?
|
Ligaments | 2 | 2014 | 33 | 0.580 |
Why?
|
Periodicals as Topic | 1 | 2019 | 168 | 0.580 |
Why?
|
Skin Neoplasms | 2 | 2014 | 580 | 0.580 |
Why?
|
Fracture Fixation | 2 | 2015 | 31 | 0.580 |
Why?
|
United States | 16 | 2024 | 6989 | 0.580 |
Why?
|
Gymnastics | 1 | 2017 | 3 | 0.580 |
Why?
|
Osteoporosis | 1 | 2018 | 122 | 0.570 |
Why?
|
Osteoporotic Fractures | 2 | 2015 | 47 | 0.570 |
Why?
|
Cumulative Trauma Disorders | 1 | 2017 | 18 | 0.560 |
Why?
|
Arthritis | 2 | 2014 | 47 | 0.560 |
Why?
|
Collagen Type II | 1 | 2016 | 14 | 0.560 |
Why?
|
Tendons | 2 | 2007 | 44 | 0.550 |
Why?
|
Bone Remodeling | 2 | 2015 | 24 | 0.550 |
Why?
|
Receptors, G-Protein-Coupled | 2 | 2014 | 129 | 0.540 |
Why?
|
Shoulder Injuries | 1 | 2016 | 17 | 0.540 |
Why?
|
Ligaments, Articular | 3 | 2013 | 38 | 0.540 |
Why?
|
Arthritis, Rheumatoid | 2 | 2016 | 170 | 0.540 |
Why?
|
Injections | 3 | 2021 | 116 | 0.540 |
Why?
|
Hand Injuries | 2 | 2013 | 16 | 0.530 |
Why?
|
Tendinopathy | 3 | 2019 | 5 | 0.520 |
Why?
|
Carcinoma, Squamous Cell | 2 | 2014 | 1096 | 0.500 |
Why?
|
Follow-Up Studies | 5 | 2023 | 3666 | 0.500 |
Why?
|
Blood Transfusion, Autologous | 2 | 2013 | 16 | 0.500 |
Why?
|
Rotator Cuff | 1 | 2015 | 41 | 0.490 |
Why?
|
Osteoporosis, Postmenopausal | 1 | 2015 | 33 | 0.490 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 319 | 0.490 |
Why?
|
Coronavirus Infections | 1 | 2020 | 304 | 0.490 |
Why?
|
Incidence | 7 | 2021 | 1595 | 0.480 |
Why?
|
Peer Review, Research | 1 | 2014 | 36 | 0.480 |
Why?
|
Veterans | 1 | 2015 | 84 | 0.480 |
Why?
|
Shoulder Dislocation | 2 | 2011 | 17 | 0.470 |
Why?
|
Synovial Membrane | 1 | 2014 | 28 | 0.470 |
Why?
|
Treatment Outcome | 11 | 2022 | 8241 | 0.470 |
Why?
|
Injections, Intra-Articular | 4 | 2018 | 27 | 0.470 |
Why?
|
Radial Nerve | 2 | 2024 | 3 | 0.460 |
Why?
|
Surveys and Questionnaires | 7 | 2016 | 2624 | 0.460 |
Why?
|
Aged, 80 and over | 12 | 2024 | 6811 | 0.460 |
Why?
|
Immunocompromised Host | 2 | 2014 | 142 | 0.460 |
Why?
|
Retrospective Studies | 11 | 2024 | 9057 | 0.450 |
Why?
|
Clinical Trials as Topic | 2 | 2019 | 1150 | 0.440 |
Why?
|
Metacarpophalangeal Joint | 1 | 2013 | 9 | 0.440 |
Why?
|
Vitamin D | 1 | 2015 | 269 | 0.440 |
Why?
|
Platelet-Rich Plasma | 1 | 2013 | 11 | 0.430 |
Why?
|
Age Factors | 7 | 2015 | 1870 | 0.430 |
Why?
|
Adolescent | 10 | 2024 | 9263 | 0.430 |
Why?
|
Rheumatic Diseases | 1 | 2013 | 26 | 0.420 |
Why?
|
Disability Evaluation | 3 | 2021 | 140 | 0.420 |
Why?
|
Sports | 1 | 2013 | 40 | 0.420 |
Why?
|
Postoperative Complications | 5 | 2024 | 2284 | 0.400 |
Why?
|
Pain Measurement | 3 | 2021 | 329 | 0.400 |
Why?
|
Personnel Staffing and Scheduling | 2 | 2016 | 94 | 0.400 |
Why?
|
Cohort Studies | 6 | 2018 | 2872 | 0.390 |
Why?
|
Biomarkers | 5 | 2016 | 1767 | 0.390 |
Why?
|
Musculoskeletal System | 1 | 2011 | 15 | 0.390 |
Why?
|
Fellowships and Scholarships | 2 | 2014 | 122 | 0.380 |
Why?
|
Biocompatible Materials | 2 | 2019 | 198 | 0.380 |
Why?
|
Sodium Chloride | 1 | 2011 | 88 | 0.380 |
Why?
|
Carbon | 1 | 2011 | 90 | 0.370 |
Why?
|
Certification | 1 | 2011 | 61 | 0.370 |
Why?
|
Surgical Wound Infection | 2 | 2024 | 201 | 0.370 |
Why?
|
Primary Health Care | 1 | 2014 | 351 | 0.370 |
Why?
|
Blast Injuries | 1 | 2010 | 11 | 0.370 |
Why?
|
Viscosupplements | 1 | 2010 | 5 | 0.360 |
Why?
|
Sports Medicine | 1 | 2011 | 58 | 0.360 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 3 | 2016 | 374 | 0.350 |
Why?
|
Intra-Articular Fractures | 1 | 2010 | 5 | 0.350 |
Why?
|
Organ Transplantation | 1 | 2014 | 276 | 0.350 |
Why?
|
Databases, Factual | 4 | 2021 | 856 | 0.350 |
Why?
|
Foreign Bodies | 1 | 2010 | 66 | 0.340 |
Why?
|
Growth Differentiation Factors | 3 | 2019 | 57 | 0.340 |
Why?
|
Isometric Contraction | 1 | 2009 | 42 | 0.340 |
Why?
|
Case-Control Studies | 3 | 2020 | 1862 | 0.330 |
Why?
|
Ankle Injuries | 2 | 2011 | 29 | 0.330 |
Why?
|
Sweden | 2 | 2020 | 40 | 0.330 |
Why?
|
Professional Competence | 1 | 2009 | 69 | 0.320 |
Why?
|
Cross-Sectional Studies | 5 | 2023 | 1714 | 0.320 |
Why?
|
Carpal Joints | 1 | 2008 | 1 | 0.320 |
Why?
|
Logistic Models | 3 | 2020 | 1213 | 0.320 |
Why?
|
Receptors, Notch | 2 | 2019 | 123 | 0.320 |
Why?
|
Upper Extremity | 3 | 2021 | 52 | 0.310 |
Why?
|
Interinstitutional Relations | 1 | 2008 | 29 | 0.310 |
Why?
|
Cell Differentiation | 6 | 2019 | 1525 | 0.310 |
Why?
|
Carpal Bones | 2 | 2012 | 12 | 0.300 |
Why?
|
Fractures, Closed | 1 | 2007 | 9 | 0.300 |
Why?
|
Blood Glucose | 2 | 2024 | 836 | 0.290 |
Why?
|
Internal Medicine | 1 | 2011 | 355 | 0.290 |
Why?
|
Rupture | 3 | 2016 | 61 | 0.290 |
Why?
|
Disease Progression | 4 | 2020 | 1489 | 0.280 |
Why?
|
Myositis Ossificans | 1 | 2006 | 3 | 0.280 |
Why?
|
Sensitivity and Specificity | 5 | 2019 | 2015 | 0.270 |
Why?
|
Bone Screws | 2 | 2020 | 45 | 0.270 |
Why?
|
Absorptiometry, Photon | 2 | 2018 | 99 | 0.270 |
Why?
|
Bone Transplantation | 2 | 2010 | 66 | 0.270 |
Why?
|
Registries | 3 | 2021 | 784 | 0.270 |
Why?
|
Rare Diseases | 1 | 2006 | 70 | 0.270 |
Why?
|
Cholagogues and Choleretics | 1 | 2005 | 10 | 0.260 |
Why?
|
Health Knowledge, Attitudes, Practice | 2 | 2016 | 533 | 0.260 |
Why?
|
Ursodeoxycholic Acid | 1 | 2005 | 25 | 0.260 |
Why?
|
Research Design | 2 | 2019 | 599 | 0.260 |
Why?
|
Splints | 3 | 2013 | 10 | 0.260 |
Why?
|
Fluoroscopy | 2 | 2012 | 123 | 0.260 |
Why?
|
Cholangitis, Sclerosing | 1 | 2005 | 51 | 0.250 |
Why?
|
Muscle, Skeletal | 1 | 2008 | 468 | 0.250 |
Why?
|
Risk Assessment | 4 | 2024 | 2303 | 0.250 |
Why?
|
Attitude to Computers | 1 | 2004 | 12 | 0.240 |
Why?
|
Electronic Mail | 1 | 2004 | 15 | 0.240 |
Why?
|
Foot Injuries | 1 | 2004 | 10 | 0.240 |
Why?
|
Matrix Metalloproteinase 1 | 2 | 2014 | 17 | 0.240 |
Why?
|
Fractures, Multiple | 1 | 2023 | 3 | 0.230 |
Why?
|
Preoperative Period | 1 | 2024 | 94 | 0.230 |
Why?
|
Kidney Transplantation | 1 | 2011 | 850 | 0.230 |
Why?
|
Practice Patterns, Physicians' | 2 | 2011 | 601 | 0.230 |
Why?
|
Exsanguination | 1 | 2023 | 1 | 0.220 |
Why?
|
Early Ambulation | 1 | 2023 | 25 | 0.220 |
Why?
|
Joint Capsule Release | 2 | 2013 | 2 | 0.220 |
Why?
|
Forearm | 1 | 2023 | 31 | 0.220 |
Why?
|
Peripheral Nerves | 1 | 2023 | 37 | 0.220 |
Why?
|
Multivariate Analysis | 3 | 2011 | 988 | 0.220 |
Why?
|
Hyperglycemia | 1 | 2024 | 172 | 0.210 |
Why?
|
Child | 5 | 2022 | 7174 | 0.210 |
Why?
|
Ambulatory Care | 1 | 2024 | 187 | 0.210 |
Why?
|
Observer Variation | 3 | 2015 | 610 | 0.210 |
Why?
|
Analysis of Variance | 3 | 2018 | 899 | 0.210 |
Why?
|
Sickness Impact Profile | 1 | 2002 | 26 | 0.210 |
Why?
|
Biomechanical Phenomena | 3 | 2014 | 476 | 0.210 |
Why?
|
Self-Assessment | 1 | 2002 | 47 | 0.200 |
Why?
|
Internet | 1 | 2004 | 319 | 0.200 |
Why?
|
Prevalence | 2 | 2024 | 1243 | 0.200 |
Why?
|
Hand Strength | 2 | 2020 | 52 | 0.200 |
Why?
|
Depressive Disorder, Major | 1 | 2023 | 166 | 0.200 |
Why?
|
Physicians | 1 | 2009 | 690 | 0.200 |
Why?
|
Bursa, Synovial | 1 | 2021 | 3 | 0.190 |
Why?
|
Lunate Bone | 1 | 2001 | 2 | 0.190 |
Why?
|
Peripheral Nerve Injuries | 1 | 2021 | 15 | 0.190 |
Why?
|
Shoulder Joint | 1 | 2002 | 91 | 0.190 |
Why?
|
Fascia | 1 | 2001 | 30 | 0.190 |
Why?
|
Recovery of Function | 2 | 2013 | 293 | 0.190 |
Why?
|
Venous Thrombosis | 1 | 2004 | 253 | 0.190 |
Why?
|
Patient Education as Topic | 1 | 2004 | 360 | 0.190 |
Why?
|
Violence | 1 | 2023 | 153 | 0.190 |
Why?
|
Vascular System Injuries | 1 | 2021 | 30 | 0.190 |
Why?
|
Median Nerve | 1 | 2020 | 12 | 0.180 |
Why?
|
Postoperative Care | 2 | 2018 | 231 | 0.180 |
Why?
|
Artificial Intelligence | 1 | 2023 | 322 | 0.180 |
Why?
|
Sampling Studies | 1 | 2020 | 72 | 0.180 |
Why?
|
Bone Plates | 1 | 2020 | 23 | 0.180 |
Why?
|
Quality of Health Care | 1 | 2023 | 385 | 0.180 |
Why?
|
Open Access Publishing | 1 | 2019 | 1 | 0.170 |
Why?
|
Patient Reported Outcome Measures | 1 | 2021 | 192 | 0.170 |
Why?
|
Peripheral Vascular Diseases | 1 | 2020 | 61 | 0.170 |
Why?
|
Scientific Misconduct | 1 | 2019 | 10 | 0.170 |
Why?
|
Peer Review | 1 | 2019 | 23 | 0.170 |
Why?
|
Fatal Outcome | 1 | 2020 | 299 | 0.170 |
Why?
|
Surgeons | 1 | 2023 | 248 | 0.170 |
Why?
|
Age Distribution | 2 | 2010 | 200 | 0.170 |
Why?
|
Signal Transduction | 3 | 2019 | 3385 | 0.170 |
Why?
|
Ethics, Research | 1 | 2019 | 52 | 0.160 |
Why?
|
Blood Coagulation Disorders | 1 | 2020 | 66 | 0.160 |
Why?
|
Transfection | 2 | 2019 | 911 | 0.160 |
Why?
|
Bioprinting | 1 | 2019 | 13 | 0.160 |
Why?
|
Minimal Clinically Important Difference | 1 | 2018 | 2 | 0.160 |
Why?
|
Hajdu-Cheney Syndrome | 1 | 2018 | 1 | 0.160 |
Why?
|
Athletes | 2 | 2016 | 52 | 0.160 |
Why?
|
Receptor, Notch2 | 1 | 2018 | 6 | 0.160 |
Why?
|
Colitis, Ulcerative | 1 | 2005 | 739 | 0.160 |
Why?
|
Umbilical Cord | 1 | 2018 | 40 | 0.160 |
Why?
|
Publishing | 1 | 2019 | 90 | 0.160 |
Why?
|
Manipulation, Orthopedic | 1 | 2018 | 5 | 0.160 |
Why?
|
Stress, Mechanical | 2 | 2011 | 253 | 0.160 |
Why?
|
Adipogenesis | 1 | 2018 | 39 | 0.160 |
Why?
|
Hydrogels | 1 | 2019 | 86 | 0.160 |
Why?
|
RNA, Long Noncoding | 1 | 2019 | 117 | 0.160 |
Why?
|
Physician's Role | 1 | 2020 | 177 | 0.150 |
Why?
|
Tissue Scaffolds | 1 | 2019 | 112 | 0.150 |
Why?
|
Terminology as Topic | 1 | 2019 | 221 | 0.150 |
Why?
|
Colorectal Neoplasms | 1 | 2005 | 981 | 0.150 |
Why?
|
Patient Positioning | 1 | 2018 | 65 | 0.150 |
Why?
|
Critical Illness | 1 | 2020 | 306 | 0.150 |
Why?
|
Severity of Illness Index | 2 | 2015 | 1840 | 0.140 |
Why?
|
Knee Joint | 1 | 2018 | 165 | 0.140 |
Why?
|
Patient Discharge | 1 | 2020 | 320 | 0.140 |
Why?
|
Tissue Engineering | 1 | 2019 | 185 | 0.140 |
Why?
|
Cranial Sutures | 1 | 2017 | 47 | 0.140 |
Why?
|
Betacoronavirus | 1 | 2020 | 261 | 0.140 |
Why?
|
Weight-Bearing | 1 | 2017 | 67 | 0.140 |
Why?
|
Retroviridae | 1 | 2017 | 79 | 0.140 |
Why?
|
Critical Care | 1 | 2020 | 382 | 0.140 |
Why?
|
Women, Working | 1 | 2016 | 7 | 0.140 |
Why?
|
Founder Effect | 1 | 2017 | 104 | 0.140 |
Why?
|
Orthopedic Surgeons | 1 | 2016 | 14 | 0.140 |
Why?
|
Tomography, X-Ray Computed | 3 | 2018 | 2661 | 0.140 |
Why?
|
Receptor, Notch1 | 1 | 2017 | 94 | 0.140 |
Why?
|
Intensive Care Units | 1 | 2020 | 396 | 0.140 |
Why?
|
Craniosynostoses | 1 | 2017 | 77 | 0.140 |
Why?
|
Diabetes Mellitus | 2 | 2018 | 742 | 0.130 |
Why?
|
Neovascularization, Physiologic | 1 | 2017 | 143 | 0.130 |
Why?
|
Combined Modality Therapy | 1 | 2020 | 1719 | 0.130 |
Why?
|
Anterior Cruciate Ligament | 1 | 2016 | 50 | 0.130 |
Why?
|
Regression Analysis | 2 | 2011 | 590 | 0.130 |
Why?
|
Anti-Bacterial Agents | 1 | 2021 | 788 | 0.130 |
Why?
|
Osteocalcin | 1 | 2015 | 26 | 0.130 |
Why?
|
Ultrasonography | 1 | 2018 | 712 | 0.130 |
Why?
|
Physicians, Women | 1 | 2016 | 56 | 0.130 |
Why?
|
Alkaline Phosphatase | 1 | 2015 | 132 | 0.130 |
Why?
|
Collagen Type I | 1 | 2015 | 72 | 0.130 |
Why?
|
Auditory Threshold | 1 | 2015 | 15 | 0.130 |
Why?
|
Career Choice | 1 | 2016 | 148 | 0.120 |
Why?
|
Cochlear Implantation | 1 | 2015 | 33 | 0.120 |
Why?
|
Epidemiologic Research Design | 1 | 2014 | 22 | 0.120 |
Why?
|
Rotator Cuff Injuries | 1 | 2015 | 43 | 0.120 |
Why?
|
Hearing | 1 | 2015 | 57 | 0.120 |
Why?
|
Parathyroid Hormone | 1 | 2015 | 217 | 0.120 |
Why?
|
Matrix Metalloproteinase 13 | 1 | 2014 | 7 | 0.120 |
Why?
|
Femoral Fractures | 1 | 2014 | 27 | 0.120 |
Why?
|
Fracture Healing | 1 | 2014 | 36 | 0.120 |
Why?
|
Hearing Loss | 1 | 2015 | 59 | 0.120 |
Why?
|
Predictive Value of Tests | 2 | 2024 | 1723 | 0.120 |
Why?
|
Wound Healing | 2 | 2011 | 359 | 0.120 |
Why?
|
Matrix Metalloproteinase 3 | 1 | 2014 | 10 | 0.120 |
Why?
|
Femur | 1 | 2015 | 111 | 0.120 |
Why?
|
Colorado | 1 | 2014 | 37 | 0.120 |
Why?
|
Scapula | 1 | 2014 | 24 | 0.120 |
Why?
|
Pandemics | 1 | 2020 | 773 | 0.110 |
Why?
|
Lumbar Vertebrae | 1 | 2015 | 151 | 0.110 |
Why?
|
Wnt Proteins | 1 | 2014 | 130 | 0.110 |
Why?
|
Linear Models | 1 | 2015 | 421 | 0.110 |
Why?
|
Methylprednisolone | 1 | 2013 | 64 | 0.110 |
Why?
|
Guidelines as Topic | 1 | 2014 | 160 | 0.110 |
Why?
|
Pain | 2 | 2019 | 400 | 0.110 |
Why?
|
Arthroscopes | 1 | 2012 | 1 | 0.110 |
Why?
|
Joint Capsule | 1 | 2012 | 6 | 0.110 |
Why?
|
Ganglia | 1 | 2012 | 14 | 0.110 |
Why?
|
Remission, Spontaneous | 1 | 2012 | 53 | 0.110 |
Why?
|
Guideline Adherence | 1 | 2014 | 230 | 0.110 |
Why?
|
Reoperation | 1 | 2015 | 599 | 0.110 |
Why?
|
HEK293 Cells | 3 | 2019 | 640 | 0.100 |
Why?
|
Palmar Plate | 1 | 2012 | 1 | 0.100 |
Why?
|
Canada | 2 | 2014 | 208 | 0.100 |
Why?
|
Academic Medical Centers | 1 | 2015 | 385 | 0.100 |
Why?
|
Peptides | 1 | 2015 | 648 | 0.100 |
Why?
|
Humerus | 2 | 2009 | 31 | 0.100 |
Why?
|
Up-Regulation | 2 | 2018 | 727 | 0.100 |
Why?
|
Mutation | 2 | 2018 | 4143 | 0.100 |
Why?
|
Arthrometry, Articular | 1 | 2011 | 3 | 0.100 |
Why?
|
Reference Values | 1 | 2013 | 661 | 0.100 |
Why?
|
Ehlers-Danlos Syndrome | 1 | 2011 | 8 | 0.100 |
Why?
|
Marfan Syndrome | 1 | 2011 | 28 | 0.100 |
Why?
|
Patient Readmission | 1 | 2015 | 352 | 0.100 |
Why?
|
Equipment Design | 1 | 2012 | 417 | 0.100 |
Why?
|
Baseball | 1 | 2011 | 18 | 0.100 |
Why?
|
Monteggia's Fracture | 1 | 2011 | 1 | 0.090 |
Why?
|
Shoulder | 1 | 2011 | 42 | 0.090 |
Why?
|
Knee Injuries | 1 | 2011 | 54 | 0.090 |
Why?
|
Anterior Cruciate Ligament Injuries | 1 | 2011 | 40 | 0.090 |
Why?
|
Specialties, Surgical | 1 | 2011 | 66 | 0.090 |
Why?
|
Attitude of Health Personnel | 2 | 2016 | 645 | 0.090 |
Why?
|
Biopsy, Needle | 1 | 2011 | 233 | 0.090 |
Why?
|
Metacarpal Bones | 1 | 2010 | 12 | 0.090 |
Why?
|
Poisson Distribution | 1 | 2010 | 50 | 0.090 |
Why?
|
Metals | 1 | 2010 | 93 | 0.090 |
Why?
|
Hyaluronic Acid | 1 | 2010 | 49 | 0.090 |
Why?
|
Confidence Intervals | 1 | 2010 | 225 | 0.090 |
Why?
|
Program Evaluation | 1 | 2011 | 307 | 0.090 |
Why?
|
Limb Salvage | 1 | 2010 | 35 | 0.090 |
Why?
|
Diagnosis, Differential | 2 | 2011 | 1597 | 0.090 |
Why?
|
Physician-Patient Relations | 1 | 2015 | 625 | 0.090 |
Why?
|
Skin Transplantation | 1 | 2011 | 184 | 0.080 |
Why?
|
Forearm Injuries | 1 | 2009 | 4 | 0.080 |
Why?
|
Syndrome | 1 | 2010 | 449 | 0.080 |
Why?
|
RNA, Messenger | 2 | 2014 | 2017 | 0.080 |
Why?
|
Epidemiologic Methods | 1 | 2009 | 60 | 0.080 |
Why?
|
Databases as Topic | 1 | 2009 | 94 | 0.080 |
Why?
|
Statistics as Topic | 1 | 2010 | 234 | 0.080 |
Why?
|
Matrix Metalloproteinases | 1 | 2009 | 29 | 0.080 |
Why?
|
Thigh | 1 | 2008 | 39 | 0.080 |
Why?
|
Quality of Life | 2 | 2019 | 1668 | 0.080 |
Why?
|
Risk | 1 | 2010 | 657 | 0.080 |
Why?
|
Sex Distribution | 1 | 2008 | 171 | 0.080 |
Why?
|
Hormone Replacement Therapy | 1 | 2009 | 85 | 0.080 |
Why?
|
Cell Proliferation | 3 | 2019 | 1652 | 0.070 |
Why?
|
Travel | 1 | 2008 | 71 | 0.070 |
Why?
|
Fractures, Comminuted | 1 | 2007 | 6 | 0.070 |
Why?
|
Living Donors | 1 | 2011 | 339 | 0.070 |
Why?
|
Immobilization | 1 | 2007 | 21 | 0.070 |
Why?
|
Arthralgia | 1 | 2007 | 39 | 0.070 |
Why?
|
Child, Preschool | 2 | 2015 | 3731 | 0.070 |
Why?
|
Glucose | 1 | 2010 | 630 | 0.070 |
Why?
|
Education, Medical, Graduate | 1 | 2011 | 393 | 0.070 |
Why?
|
Collagen | 1 | 2009 | 293 | 0.070 |
Why?
|
Kidney Failure, Chronic | 1 | 2011 | 414 | 0.070 |
Why?
|
Mice | 5 | 2019 | 11761 | 0.070 |
Why?
|
Immunohistochemistry | 1 | 2011 | 1799 | 0.070 |
Why?
|
Bone Diseases | 1 | 2006 | 57 | 0.070 |
Why?
|
Mucopolysaccharidoses | 1 | 2006 | 1 | 0.070 |
Why?
|
Muscular Diseases | 1 | 2006 | 64 | 0.070 |
Why?
|
Intraoperative Period | 2 | 2012 | 90 | 0.070 |
Why?
|
Cells, Cultured | 3 | 2019 | 2884 | 0.060 |
Why?
|
Clinical Competence | 1 | 2011 | 784 | 0.060 |
Why?
|
Neoplasm Staging | 1 | 2011 | 2018 | 0.060 |
Why?
|
Recurrence | 1 | 2008 | 1144 | 0.060 |
Why?
|
Age of Onset | 1 | 2005 | 312 | 0.060 |
Why?
|
Rectum | 1 | 2005 | 148 | 0.060 |
Why?
|
Animals | 7 | 2019 | 27371 | 0.060 |
Why?
|
Amyloidosis | 1 | 2006 | 127 | 0.060 |
Why?
|
Health Facilities | 1 | 2023 | 36 | 0.060 |
Why?
|
Attitude | 1 | 2004 | 130 | 0.060 |
Why?
|
Cell Line | 2 | 2019 | 2496 | 0.060 |
Why?
|
Diagnostic Imaging | 1 | 2007 | 479 | 0.050 |
Why?
|
Lower Extremity | 1 | 2023 | 88 | 0.050 |
Why?
|
Documentation | 1 | 2023 | 103 | 0.050 |
Why?
|
Anxiety Disorders | 1 | 2023 | 152 | 0.050 |
Why?
|
Mice, Transgenic | 2 | 2018 | 1574 | 0.050 |
Why?
|
Benchmarking | 1 | 2023 | 79 | 0.050 |
Why?
|
Colon | 1 | 2005 | 510 | 0.050 |
Why?
|
Chondrosarcoma | 1 | 2002 | 48 | 0.050 |
Why?
|
Thymidine | 1 | 2001 | 59 | 0.050 |
Why?
|
Chondrocytes | 1 | 2001 | 64 | 0.050 |
Why?
|
Gene Expression | 2 | 2017 | 1310 | 0.050 |
Why?
|
Anxiety | 1 | 2023 | 308 | 0.050 |
Why?
|
Gadolinium | 1 | 2001 | 103 | 0.050 |
Why?
|
Anesthesia, Local | 1 | 2020 | 27 | 0.050 |
Why?
|
Trauma Centers | 1 | 2021 | 146 | 0.040 |
Why?
|
Anesthetics, Local | 1 | 2020 | 76 | 0.040 |
Why?
|
Communication | 1 | 2023 | 460 | 0.040 |
Why?
|
Antigens, Neoplasm | 1 | 2002 | 332 | 0.040 |
Why?
|
Transplantation, Autologous | 1 | 2001 | 344 | 0.040 |
Why?
|
Depression | 1 | 2023 | 505 | 0.040 |
Why?
|
Delphi Technique | 1 | 2019 | 92 | 0.040 |
Why?
|
Chitosan | 1 | 2019 | 18 | 0.040 |
Why?
|
Magnetic Resonance Imaging | 1 | 2011 | 3448 | 0.040 |
Why?
|
Consensus | 1 | 2021 | 356 | 0.040 |
Why?
|
Bone Regeneration | 1 | 2019 | 59 | 0.040 |
Why?
|
Health Care Surveys | 1 | 2019 | 280 | 0.040 |
Why?
|
Transposon Resolvases | 1 | 2018 | 7 | 0.040 |
Why?
|
Triamcinolone | 1 | 2018 | 18 | 0.040 |
Why?
|
Chondrogenesis | 1 | 2018 | 28 | 0.040 |
Why?
|
Antigens, Polyomavirus Transforming | 1 | 2018 | 47 | 0.040 |
Why?
|
Real-Time Polymerase Chain Reaction | 1 | 2019 | 282 | 0.040 |
Why?
|
Calcium Phosphates | 1 | 2019 | 77 | 0.040 |
Why?
|
Activities of Daily Living | 1 | 2019 | 207 | 0.040 |
Why?
|
Mice, 129 Strain | 1 | 2018 | 56 | 0.040 |
Why?
|
Neoplasm Proteins | 1 | 2002 | 540 | 0.040 |
Why?
|
Liver Transplantation | 1 | 2005 | 1180 | 0.040 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2018 | 1942 | 0.040 |
Why?
|
Pain, Postoperative | 1 | 2020 | 252 | 0.040 |
Why?
|
In Vitro Techniques | 1 | 2019 | 996 | 0.040 |
Why?
|
Hydrogen-Ion Concentration | 1 | 2019 | 501 | 0.040 |
Why?
|
Cell Adhesion | 1 | 2019 | 426 | 0.040 |
Why?
|
Reproducibility of Results | 2 | 2014 | 2758 | 0.040 |
Why?
|
Cell Culture Techniques | 1 | 2018 | 192 | 0.040 |
Why?
|
Nanoparticles | 1 | 2019 | 164 | 0.040 |
Why?
|
Simian virus 40 | 1 | 2017 | 35 | 0.040 |
Why?
|
Transformation, Genetic | 1 | 2017 | 41 | 0.040 |
Why?
|
Receptors, Virus | 1 | 2017 | 75 | 0.040 |
Why?
|
Cell Line, Transformed | 1 | 2017 | 155 | 0.040 |
Why?
|
Virion | 1 | 2017 | 59 | 0.040 |
Why?
|
Work-Life Balance | 1 | 2016 | 6 | 0.040 |
Why?
|
Osteoblasts | 1 | 2017 | 98 | 0.040 |
Why?
|
Job Description | 1 | 2016 | 9 | 0.030 |
Why?
|
Genetic Vectors | 1 | 2018 | 446 | 0.030 |
Why?
|
Genes, Reporter | 1 | 2017 | 275 | 0.030 |
Why?
|
Mice, Nude | 1 | 2018 | 815 | 0.030 |
Why?
|
Green Fluorescent Proteins | 1 | 2017 | 309 | 0.030 |
Why?
|
Job Satisfaction | 1 | 2016 | 78 | 0.030 |
Why?
|
Adipocytes | 1 | 2017 | 162 | 0.030 |
Why?
|
Hypoglycemic Agents | 1 | 2018 | 349 | 0.030 |
Why?
|
Mentors | 1 | 2016 | 87 | 0.030 |
Why?
|
Perception | 1 | 2016 | 179 | 0.030 |
Why?
|
Hearing Tests | 1 | 2015 | 11 | 0.030 |
Why?
|
Audiometry, Pure-Tone | 1 | 2015 | 25 | 0.030 |
Why?
|
Cochlear Implants | 1 | 2015 | 35 | 0.030 |
Why?
|
Body Mass Index | 1 | 2018 | 773 | 0.030 |
Why?
|
Apoptosis | 1 | 2001 | 1717 | 0.030 |
Why?
|
Bony Callus | 1 | 2014 | 5 | 0.030 |
Why?
|
Wnt-5a Protein | 1 | 2014 | 10 | 0.030 |
Why?
|
South Africa | 1 | 2014 | 60 | 0.030 |
Why?
|
Cartilage | 1 | 2014 | 116 | 0.030 |
Why?
|
Haploinsufficiency | 1 | 2014 | 65 | 0.030 |
Why?
|
Osteophyte | 1 | 2013 | 2 | 0.030 |
Why?
|
United Kingdom | 1 | 2014 | 164 | 0.030 |
Why?
|
International Cooperation | 1 | 2014 | 125 | 0.030 |
Why?
|
Ulnar Nerve | 1 | 2013 | 7 | 0.030 |
Why?
|
Iatrogenic Disease | 1 | 2013 | 70 | 0.030 |
Why?
|
Insulin | 1 | 2018 | 1146 | 0.030 |
Why?
|
Decompression, Surgical | 1 | 2013 | 87 | 0.030 |
Why?
|
Pronation | 1 | 2012 | 6 | 0.030 |
Why?
|
Supination | 1 | 2012 | 6 | 0.030 |
Why?
|
Infant, Newborn | 1 | 2018 | 2486 | 0.030 |
Why?
|
Cadaver | 1 | 2012 | 185 | 0.020 |
Why?
|
Statistics, Nonparametric | 1 | 2012 | 306 | 0.020 |
Why?
|
Mice, Inbred C57BL | 1 | 2018 | 3218 | 0.020 |
Why?
|
Cell Line, Tumor | 1 | 2017 | 2558 | 0.020 |
Why?
|
Gene Expression Regulation | 1 | 2019 | 1976 | 0.020 |
Why?
|
Infant | 1 | 2017 | 3160 | 0.020 |
Why?
|
Imaging, Three-Dimensional | 1 | 2014 | 598 | 0.020 |
Why?
|
Time Factors | 1 | 1999 | 5338 | 0.020 |
Why?
|
Disease Models, Animal | 1 | 2014 | 2366 | 0.020 |
Why?
|
Ulna | 1 | 2006 | 15 | 0.020 |
Why?
|
K562 Cells | 1 | 2002 | 44 | 0.010 |
Why?
|
Blotting, Northern | 1 | 2002 | 258 | 0.010 |
Why?
|
Tritium | 1 | 2001 | 133 | 0.010 |
Why?
|
Cattle | 1 | 2001 | 375 | 0.010 |
Why?
|
Proteoglycans | 1 | 2001 | 123 | 0.010 |
Why?
|
Alternative Splicing | 1 | 2002 | 211 | 0.010 |
Why?
|
Tumor Cells, Cultured | 1 | 2002 | 1057 | 0.010 |
Why?
|
Paclitaxel | 1 | 2002 | 479 | 0.010 |
Why?
|
Cell Division | 1 | 2001 | 696 | 0.010 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2002 | 618 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2002 | 2062 | 0.010 |
Why?
|
Base Sequence | 1 | 2002 | 2327 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2002 | 3027 | 0.010 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2002 | 1265 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2002 | 1431 | 0.010 |
Why?
|